Acorda Therapeutics, Inc. Business Combination, Contingent Consideration, Liability, Current
Acorda Therapeutics, Inc. had Business Combination, Contingent Consideration, Liability, Current of $2.97 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2024-05-14
- 2024-03-31: Business Combination, Contingent Consideration, Liability, Current $2.97M.
- 2023-12-31: Business Combination, Contingent Consideration, Liability, Current $2.13M.
- 2023-09-30: Business Combination, Contingent Consideration, Liability, Current $2.58M.
- 2023-06-30: Business Combination, Contingent Consideration, Liability, Current $3.27M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2024-03-31 | $2.97M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $2.13M 10-Q · filed 2024-05-14 |
| 2023-09-30 | $2.58M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.27M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.31M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.53M 10-K · filed 2024-04-01 |
| 2022-09-30 | $2.36M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.13M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.23M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $1.93M 10-K · filed 2023-03-15 |
| 2021-09-30 | $1.84M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $1.45M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.70M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.62M 10-K · filed 2022-03-18 |
| 2020-09-30 | $2.39M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $2.28M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.94M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $1.87M 10-K · filed 2021-03-16 |
| 2019-09-30 | $3.89M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.99M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $8.18M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $4.91M 10-K · filed 2020-02-28 |
| 2017-12-31 | $278.00K 10-K · filed 2019-02-27 |